LICHEN SIMPLEX CHRONICUS?
If you are 18 years or older and have been diagnosed with moderate to severe lichen simplex chronicus (LSC) that is not well controlled despite being on medication (persistent itching), you may qualify to participate in a clinical research study.
This study aims to evaluate the safety and effectiveness of an investigational medicinal product, Dupilumab, in treating LSC.
If you are eligible, you may receive the following at no cost:
- Study-related medical examinations.
- Study-related investigational medication.
- Compensation for time and travel (where permitted).
Interested in learning more? Please click the link below to fill out our eligibility questionnaire, indicating your preferred contact time. Once we receive your completed form, we’ll be in touch with additional study details.
or contact
Stemax Consult Healthcare Services
Site Contact: Olu Ijeh – 01908 032992
Email: admin@stemaxconsult.com
https://youtube.com/shorts/dW1VFRXRPHg?si=iWZ0KPhAjlCedcDx
